Symposium 17
Identifying and fixing dysfunctional circuits in depression: leveraging systems neuroscience and translational approaches for developing novel targets and therapeutics.

[IS17-2] Targeting Basal Ganglia Circuitry for the Treatment of Major Depressive Disorder

*Anatol Kreitzer¹ (1. MapLight Therapeutics)

キーワード：major depressive disorder, GPR6, motivation, anhedonia, psychomotor retardation